Name: SLNCF Number Of Share Options Exercised In Share-based Payment Arrangement 2018-2023
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

Silence Therapeutics plc Number Of Share Options Exercised In Share-based Payment Arrangement

Silence Therapeutics plc (SLNCF) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 807.93 thousand shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.

Discontinued › Notes › Compensation Related Costs

ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2024-03-13

Period end	Number Of Share Options Exercised In Share-based Payment Arrangement 12 month
2023-12-31	807.93K shares 20-F · filed 2024-03-13
2022-12-31	173.75K shares 20-F · filed 2023-03-15
2021-12-31	411.81K shares 20-F · filed 2024-03-13
2020-12-31	659.41K shares 20-F · filed 2023-03-15
2019-12-31	2.24M shares 20-F · filed 2022-03-17
2018-12-31	1.08M shares 20-F/A · filed 2021-04-29

AmericanDepositarySh

Period end	Number Of Share Options Exercised In Share-based Payment Arrangement 12 month
2023-12-31	269.31K AmericanDepositarySh 20-F · filed 2024-03-13
2022-12-31	57.92K AmericanDepositarySh 20-F · filed 2024-03-13